Topiroxostat
- Generic Name
- Topiroxostat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C13H8N6
- CAS Number
- 577778-58-6
- Unique Ingredient Identifier
- 0J877412JV
- Background
Topiroxostat is a selective xanthine oxidase inhibitor developed for treatment and management of hyperuricemia and gout. Xanthine oxidase, or xanthine oxidoreductase (XOR), regulates purine metabolism, and inhibition of the enzyme results in efficacious reduction of serum urate levels. Xanthine oxidase inhibitors are classified into two groups; purine analog...
- Indication
Indicated for the treatment of gout and hyperurcemia in Japan.
- Associated Conditions
- -
- Associated Therapies
- -
Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types)
- First Posted Date
- 2016-07-19
- Last Posted Date
- 2018-08-21
- Lead Sponsor
- Fuji Yakuhin Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT02837198
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath